ADVERTISEMENT

Every 10 seconds an article from Annals of Surgical Oncology is downloaded.

HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY

Weekly Update

A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy

October 17, 2025.

Citation: Sturz-Ellis, J.L., Vetter, C.D., Day, C.N. et al. A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy. Ann Surg Oncol (2025). https://doi.org/10.1245/s10434-025-18474-4

Synopsis: Across 27 studies, 5728 patients underwent contralateral prophylactic mastectomy (CPM), with 87 occult malignancy (OM) identified.  OM in CPM is uncommon (1.55%), and when it occurs, it is predominantly pT1, luminal A, invasive ductal carcinoma with a limited nodal burden.

Skeletal Muscle Gauge as a Prognosticator of Survival in Resected Early-Stage Non-small Cell Lung Cancer

October 17, 2025.

Citation: Khan, A.A., Naeem, W., Ansari, M. et al. Skeletal Muscle Gauge as a Prognosticator of Survival in Resected Early-Stage Non-small Cell Lung Cancer. Ann Surg Oncol (2025). https://doi.org/10.1245/s10434-025-18553-6

Synopsis: Skeletal muscle gauge (SMG), a composite of radiologically derived muscle volume and density, as a prognostic marker in NSCLC. SMG outperformed individual indices and was independently associated with overall survival, supporting its clinical relevance as a preoperative prognosticator.

Listen to the ASO's podcast, Speaking of SurgOnc®

Speaking of SurgOnc Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).

The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who expands upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.

Listen to the podcast here.

ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.

Join the conversation! Follow the journal on Twitter and Instagram. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.

twitter icon instagram icon

Scroll to Top